Jack Reed Stock Trades

Jack Reed Trading Profile | Quantellect Jack Reed Trading Profile | Quantellect

Jack Reed's disclosed transaction dates run from February 2012 to February 2019, and the final date stands out for its sheer breadth: on February 28, 2019, twenty-five separate sales were reported in a single filing disclosed on March 18, cutting across technology, health care, industrials, consumer and energy names all at once. That was not an isolated event. Reed's last three disclosure filings, covering transactions dated November 2018 through February 2019, were composed almost entirely of sales, a sharp contrast with years like 2016 and 2014 when purchases outnumbered sales. Across the full 248-transaction record, sales (140) outweigh purchases (106) by a wide margin, and the tilt toward selling became more pronounced toward the end of the record.

The disclosed activity was also concentrated in time. Of the 248 disclosed transactions, 41 fall in 2019 alone, and every one of them is a sale. That compares with 52 transactions in 2016, split 33 purchases to 17 sales, and 37 in 2014, split 27 to 10. The later years show a staged shift in the transaction mix: 2018 contained 32 sales and one purchase, followed by 41 sales and no purchases in 2019. Across the 2018 and 2019 filings, partial sales were prominent in March 2018 before transactions recorded as “Sale (Full)” dominated the final two filings.

Most of these transactions carry a Joint attribution: 127 of the 248 disclosures are coded JT, versus 103 coded SELF, and none carry a spouse (SP) or dependent child (DC) code. Eighteen transactions have unknown attribution. That split matters. The joint account accounts for more disclosed transactions than the member's own individually coded trades. Readers should treat the Joint-coded transactions as reflecting a jointly held account rather than assuming each one was Reed's personal decision, while the unknown-attribution transactions should not be attributed to him personally.

What shows up most often in the disclosures

Measured strictly by transaction-row count, a handful of names recur repeatedly across the filing history. Celgene Corporation (CELG) and Thermo Fisher Scientific Inc. (TMO) each appear in 11 disclosed transactions, the most of any security. Thermo Fisher, a life sciences and diagnostics equipment maker, was disclosed 8 times as a purchase and 3 times as a sale, with the latest dated February 28, 2019. Danaher Corporation (DHR), another diversified life sciences and diagnostics company, follows with 9 disclosed transactions (5 purchases, 4 sales). FedEx Corporation (FDX) appears 7 times, with 3 purchases and 4 sales. The iShares Transportation Average ETF (IYT) was also disclosed 7 times, with 5 purchases and 2 sales, showing that transportation-related securities recurred in the transaction history.

Qualcomm Incorporated (QCOM) and NXP Semiconductors NV (NXPI) each show up multiple times, alongside Analog Devices (ADI), Intel (INTC), Microsoft (MSFT) and Apple (AAPL), a cluster of semiconductor and broader technology names that, together with sector-specific vehicles like the SPDR S&P Semiconductor ETF (XSD) and the ETFMG Prime Cyber Security ETF (HACK), shows recurring transaction activity across the technology and semiconductor space. Health care is even more heavily represented in raw transaction count: 49 of the 248 disclosed transactions fall in that sector, more than any other classified sector, populated by names such as Intuitive Surgical (ISRG), Stryker (SYK), Vertex Pharmaceuticals (VRTX), Amgen (AMGN), IQVIA Holdings (IQV), CVS Health (CVS) and Zimmer Biomet (ZBH). Information Technology follows with 42 transactions, then Consumer Staples and Industrials with 13 each, and Financials with 10.

It's worth noting that 116 of the 248 disclosed transactions carry no assigned sector in this dataset, including frequently disclosed tickers like IYT, XSD, VWO (Vanguard FTSE Emerging Markets ETF), TBF, WETF, XBI (SPDR S&P Biotech ETF) and NYSE. Several of these are exchange-traded funds rather than individual operating companies, which helps explain the missing sector classification and shows that ETFs appeared repeatedly within the broader disclosed activity.

The February 2019 wave of full sales

For transactions dated February 4 and February 28, 2019, the final two filings show a wave of entries recorded as “Sale (Full)” across companies including Apple, Vertex Pharmaceuticals, Honeywell International, Intel, CVS Health, IQVIA Holdings, Amgen, Cisco Systems, Illinois Tool Works, Danaher, FedEx, Stryker, Intuitive Surgical, Qualcomm, Costco, Thermo Fisher, PepsiCo, Analog Devices, Xilinx, Microsoft, Celgene, Hologic and Schlumberger Limited (SLB). Transactions recorded as “Sale (Full)” dominate these two filings, a different pattern from the mixed purchase-and-sale activity recorded in 2016 and 2017 and from the March 2018 filing, where partial sales were spread across more than a dozen names in a single disclosure. Reed's most recent disclosed transaction date on record is February 28, 2019.

The companies most repeatedly named across the disclosure history operate in distinct, well-defined businesses. Thermo Fisher Scientific supplies life sciences reagents, analytical instruments and diagnostics products used across pharmaceutical and clinical research. Danaher is similarly diversified across biotechnology, life sciences and diagnostics segments. FedEx operates an express package-delivery and logistics network, while IYT appears separately in the record as a transportation ETF. Qualcomm licenses and supplies wireless technology and integrated circuits, while NXP Semiconductors is classified in the Information Technology sector. Intuitive Surgical makes the da Vinci robotic surgical system, and Stryker supplies orthopedic implants and surgical equipment. Together, these disclosed names span health care, logistics and information technology, consistent with the sector counts across the transaction record.

Disclosure and attribution notes

This profile is built from Jack Reed's official financial disclosure filings with the U.S. Senate, made under the Stop Trading on Congressional Knowledge Act of 2012, which requires members of Congress to disclose certain covered securities transactions. Guidance on these filing requirements is maintained by the Senate Select Committee on Ethics.

Transactions coded “Joint” (JT) reflect a jointly held account and are not necessarily the result of a personal trading decision by the senator; 18 transactions in this record carry unknown attribution and are not attributed to Reed personally. Transaction amounts are disclosed as value ranges rather than exact dollar figures. As of August 21, 2026, no Quantellect Score is available for Jack Reed.